Granted Patent B2

US 9,387,168 · App. 14/283,459 · Granted Jul 12, 2016

Inventors: Jack Barreca (Highlands Ranch, CO); Joseph E. Kovarik (Englewood, CO)

A61K9/0058A23G3/362A23G3/368A23G3/48A23G3/54A23G3/545A23G4/064A23G4/068A23G4/126A23G4/20A23G4/205A61K36/258A61K36/82A23V2002/00A61Q11/00Y10S514/909

Abstract

Claims (5)

1. A chewing gum product consisting essentially of a first substance configured so as to have at least one cavity capable of retaining a liquid or semi-liquid substance as a second substance, wherein at least said second substance has an active ingredient consisting essentially of a chemotherapeutic agent and at least one ingredient selected from the group consisting of calcium, zinc, chromium picolinate, magnesium, a metabolic enhancer and combinations thereof, said active ingredient present in an amount of at least about 0.05 mg, wherein said active ingredient is present in the form of a controlled release formulation, and wherein said controlled release formulation comprises time release capsules.

2. A chewing gum product consisting essentially of a first substance configured so as to have at least one cavity capable of retaining a liquid or semi-liquid substance as a second substance, wherein at least said second substance has an active ingredient consisting essentially of a chemotherapeutic agent and at least one ingredient selected from the group consisting of a metabolic enhancer, green tea, zinc, chromium picolinate and magnesium, said active ingredient present in an amount of at least about 0.05 mg, wherein said active ingredient is present in the form of a controlled release formulation, and wherein said controlled release formulation comprises time release capsules.

3. A chewing gum product consisting essentially of a first substance configured so as to have at least one cavity capable of retaining a liquid or semi-liquid substance as a second substance, wherein at least said second substance has an active ingredient consisting essentially of a chemotherapeutic agent, calcium, zinc and magnesium, said active ingredient present in an amount of at least about 0.05 mg, wherein said active ingredient is present in the form of a controlled release formulation, and wherein said controlled release formulation comprises time release capsules.

4. The chewing gum of claim 1 wherein said active ingredient is present in an amount of more than 30 mg.

5. A chewing gum as act forth in claim 1 , wherein said controlled release formulation has desirable solubility and dissolution rates.

Assignments (1)

Continuity (8)